Previous Article in Journal
Early-Onset and Delayed-Onset Postpartum Psychosis: A Case Series
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Women
Volume 5
Issue 4
10.3390/women5040037
women-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Trends in Heart Disease Mortality Among US Female Adults Aged ≥35 Years Old in Florida: A Descriptive Analysis

by
Avanthi Puvvala
,
Atharva Rohatgi
,
Diana Lobaina
,
Megha Srivastav
,
Vama Jhumkhawala
,
Sahar Kaleem
and
Lea Sacca
*
Department of Population Health, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA
*
Author to whom correspondence should be addressed.
Women 2025, 5(4), 37; https://doi.org/10.3390/women5040037
Submission received: 12 July 2025 / Revised: 10 August 2025 / Accepted: 1 October 2025 / Published: 7 October 2025
Browse Figure
Versions Notes

Abstract

Background: Cardiovascular disease disproportionately affects women in the United States. CVD outcomes are closely tied to a multitude of factors including lifestyle habits and socioeconomic status which create a complex interweb of determinants of health that place certain age and racial groups at higher risk over others. Such inequities highlight the need for targeted prevention strategies to address the unique risks faced by different populations. In this study, a state-wide analysis examining the mortality rates among women aged 35 years or older in Florida from 2018 to 2023 was done in order to identify high risk groups to better inform evidence-based public heath interventions that are tailored to the population’s needs. Mortality rates were extracted from the CDC Wonder Database. Age-adjusted and crude mortality rates, per 100,000 women, were calculated and stratified by ten-year age groups, Hispanic origin, race, and major CVD subtypes based on various ICD-10 codes. From the ICD-10 113 Cause List, “The Diseases of the Heart” were the cause of the majority of the deaths; however, “Other Forms of Chronic Ischemic Heart Diseases” was the leading subtype. Crude rates for the “Ischemic Heart Diseases” decreased 110.9 per 100,000 women in 2018 to 101.5 per 100,000 women in 2023. Yet, the most common cause of CVD-related mortality remains ischemic heart disease. Across the study period, non-Hispanic women experienced more than twice the crude mortality rate of Hispanic women. Racial breakdowns showed that White women had the highest CVD mortality, followed by Black women, who had elevated rates of heart failure and heart attacks in comparison to other minority groups. Asian women had the lowest rates across all cardiovascular subtypes. These findings underscore the persistent age and racial differences in cardiovascular outcomes emphasize the urgent need for culturally informed, community-specific preventative interventions to improve cardiovascular care and reduce mortality within high-risk populations.

1. Introduction

In the United States, cardiovascular disease (CVD) is the leading cause of adult mortality across all races and ages; however, it disproportionately impacts women [1,2]. CVD encompasses a wide array of conditions affecting the body’s circulatory system and can often lead to substantial impacts on quality of life [3]. Interdisciplinary risk factors such as pre-existing conditions, lifestyle habits, and social determinants of health (SDOH) increase a woman’s risk of developing heart disease [4,5]. Due to CVD’s significant burden on socioeconomic status and overall health, it is imperative to understand and investigate the trends in disease incidence and prevalence to create and implement the most effective CVD prevention strategies [6].
A significant portion of women in the United States over the age of 35 suffers from some form of cardiovascular disease [7]. Additionally, recent data outlines that approximately 35% of all U.S. women live with some form of CVD [7]. In 2022 alone, heart disease was responsible for 446,912 deaths among women across all age groups, accounting for nearly 47.5% of all cardiovascular-related fatalities in the country [8]. More specifically, the incidence of both first-time CVD events and CVD-related mortality increases significantly with age among women over 35 years old [7]. Although the overall mortality from CVD has declined, with a 49% decrease between 1980 and 2002, this reduction has not been seen in mortality rates for younger women [9,10,11]. Instead, alarmingly, mortality rates have recently begun to increase in women aged 35–54 years old, emphasizing the urgency of the innovation and implementation of targeted health care solutions for this age group [10,11].
Several factors influence the elevated risk of heart disease in US adult women [12]. Broadly, modifiable risk factors such as high cholesterol, high blood pressure, and obesity play a substantial role in disease progression, highlighting the importance of lifestyle management and regular health screenings [12]. In addition, women have sex-specific biological factors that put them at risk, such as menopause. As women age, with the natural decline in their estrogen levels comes the loss of the hormone’s cardiovascular protective effects, increasing susceptibility to heart disease [12]. Additionally, women with a history of pregnancy-related complications such as gestational hypertension or diabetes can also increase the long-term likelihood of developing CVD [12]. In terms of lifestyle factors, smoking can present as greater danger to women’s heart health than men’s, underscoring the importance and need for smoking cessation efforts focused on women [12].
Similarly to national trends, Florida has witnessed a steady decline in death rates from heart disease between 2000 and 2020 (160 per 100,000 to 110 per 100,000) [13]. This positive trend likely reflects improved awareness, prevention strategies, and advancements in treatment [13]. However, CVD remains the leading cause of death in women in Florida, with an average of every 1 in 5 adult women living with heart disease [14]. Notably, younger women in Florida (also under 55) have not seen the same level of improvement in mortality rates over time, highlighting that early prevention efforts remain critically important for this demographic [14]. Recent research depicts a concerning stagnation of heart disease mortality rates among younger women, particularly those aged 35 to 54, further suggesting that the progress in declining incidence has not yet translated to this age group [15,16]. Furthermore, younger women who experience heart attacks in this state often present with symptoms that greatly differ from classic chest pain [16,17]. Instead, women can present with shortness of breath, fatigue, dizziness, cold sweats, or pain in the neck or jaw, leading to potentially further delays in diagnosis and treatment [16,17]. Additionally, recent data in Florida shows an upward trend in the average age of patients admitted for cardiovascular events, emphasizing the need for strategic healthcare planning and resource allocation [18]. It is also crucial to recognize that the development and progression of CVD are not solely determined by individual biological factors but rather also by social determinants of health (SDOH) [19]. SDOH encompass a broad spectrum of factors that shape people’s lives, including their economic stability, level of education, access to nutritious food, availability of quality healthcare, and racial and ethnic differences [19]. For instance, Black and Hispanic populations in the United States experience disproportionately higher rates of hypertension, heart failure, and CVD-related mortality compared to non-Hispanic White populations [20]. These differences are often driven by systemic barriers, including structural racism, limited access to preventive care, and chronic exposure to social and economic stressors [21]. Additionally, other research studies conducted in Florida have shown that factors such as economic instability, lower education attainment, limited access to green spaces, and food insecurity all contribute to higher CVD risk [22,23,24]. As such, it is imperative to create comprehensive public health programs that can be tailored to women’s specific experiences and cultural backgrounds through individualized strategies that address both personal and societal factors hindering access to care [22,23,24].
Despite the large health impact that heart disease imposes on women, there are several factors that hinder effective implementation of prevention strategies [25]. For example, there is often conflicting health information in mainstream media that can make it difficult for US women with low levels of health literacy to differentiate accurate reports from falsified ones [25]. Moreover, it is more common for women to bear the burden of caretaking responsibilities which can impact their time and ability to prioritize their own heart health [25]. There also has been a paucity of representation of women in clinical trials for cardiovascular diseases, which has led to a lack of sex-specific evidence and potentially biased diagnostic and treatment guidelines [26]. Moreover, some healthcare professionals may have lower levels of knowledge regarding female-specific factors—such as pregnancy-related complications (e.g., preeclampsia, gestational diabetes), hormonal changes during menopause, and atypical presentation of symptoms like fatigue or shortness of breath rather than chest pain—to assess CVD in women [27]. Hence, more evidence-based interventions and high-impact randomized controlled trials are needed to further investigate the multifactorial obstacles to effective prevention of CVD in at-risk women.
Our descriptive study aims to explore the trends in heart disease mortality among US females aged 35 years and older currently residing in Florida. Through analysis of mortality data, this study seeks to help identify patterns, differences, and potential areas of concern within this specific demographic. The anticipated findings can inform the development and implementation of evidence-based interventions tailored to addressing the unique needs of vulnerable US female adults at high risk of dying from CVD, ultimately contributing to more effective public health strategies and improved cardiovascular outcomes in the state.

2. Results

2.1. Trends in Age-Adjusted CVD-Related Death Rates Among US Women in Florida Aged ≥35 Years Old

Age-adjusted CVD-related death rates among US women in Florida over the age of 35 years old showed an upward trend between 2018 and 2021, followed by a decline in subsequent years. In 2021, the highest age-adjusted mortality rate was observed at 96.9 deaths per 100,000 women. Prior to this, in 2018, the age-adjusted rate was 94.3 before dropping to 91.8 in 2019 and growing to 92.3 in 2020. After 2021, the rate decreased to 86.9 in 2022 before its lowest level of 86.3 in 2023. The death rate for each year was calculated by dividing the annual cardiovascular-related deaths by age-specific population counts and standardized each year through the 2000 U.S. Standard Population through the CDC Wonder Database, as shown by Figure 1.
In Table 1, the crude mortality rates are measured across ten-year age groups from 2018 to 2023. From this data, CVD-related mortality rates rise with age. The largest proportion of total deaths was observed among women greater than 85 years old, contributing approximately 49.9% of all CVD-related mortality across the measured six-year period. The age group of women older than 85 years old also had the highest peak of CVD-related mortality at 2809.2 deaths per 100,000 women in 2021. On the other hand, women aged 35–44 years old had the lowest crude mortality rates, with an average crude mortality rate of 10.3 deaths per 100,000 women from 2018 to 2023. Women aged 65–74 years had crude rates that were from 181.1 to 200.7 per 100,000 women while those aged 75–84 years had rates from 530.1 to 580.2 per 100,000 women. These findings show a clear disproportionate burden faced by older populations within the gradient of CVD-related mortality.
When the data was stratified by Hispanic origin, as shown by Table 2, across all years from 2018 to 2023, crude mortality rates among non-Hispanic women were more than twice as high as those among Hispanic women. For women greater than 35 years of age, there was a clear difference in CVD mortality between Hispanic and non-Hispanic women. In 2023, the crude mortality rate for Hispanic women was 80.2 (95% CI: 77.1–83.4), compared to 180.2 (95% CI: 177.3–183.1) for non-Hispanic women. This difference persisted across the study period, with Hispanic women experiencing the highest rate in 2020 (93.4 per 100,000) and the lowest in 2023, while non-Hispanic women’s rates remained consistently above 180. These findings highlight differences amidst social determinants of health between each group.

2.2. Trends in Crude Major CVD Mortality Rates in Women Aged ≥35 Years Old in Florida

In Table 3, the crude mortality rates for total major cardiovascular diseases declined from 165.5 per 100,000 women in 2018 to 153.1 per 100,000 women in 2023. From the ICD-10 113 Cause List, “The Diseases of the Heart” were the cause of the majority of the deaths, however “Other Forms of Chronic Ischemic Heart Diseases” was the leading subtype. Crude rates for the “Ischemic Heart Diseases” decreased 110.9 per 100,000 women in 2018 to 101.5 per 100,000 women in 2023. Within this category, “Acute Myocardial Infarction”, the crude mortality rate declined from 28.1 to 24.9 per 100,000 women, and “Atherosclerotic Cardiovascular Disease” remained stable around 20 per 100,000 women. “Heart Failure” crude mortality rates were also stable and had minimal variation from year to year. There were some modest declines in ischemic and acute cardiac events in Table 3; however, the most common cause of CVD-related mortality remains ischemic heart disease.

2.3. Ethnic Differences in Major CVD-Related Deaths in Women Aged ≥35 Years Old in Florida

Within Table 4 and Table 5 additional stratification of CVD mortality by Hispanic origin and disease subtype highlights differences between Hispanic and non-Hispanic women across every major cardiovascular cause of death. In Table 5, in 2023, non-Hispanic women had nearly double the crude mortality rate for ischemic heart disease compared to Hispanic women (118.9 vs. 54.7 per 100,000 women, respectively). Acute myocardial infarction, other chronic ischemic heart disease, and heart failure all followed similar patterns. For instance, in Table 5, in 2023, the crude rate for heart failure among non-Hispanic women was 23.6 per 100,000 women compared to 10.3 per 100,000 among Hispanic women. These variabilities remained consistent across the entire 2018–2023 period.

2.4. Racial Differences in Major CVD-Related Deaths in Women Aged ≥35 Years Old in Florida

Crude mortality rates for cardiovascular disease also varied substantially by race. In Table 6, Black women followed, with rates ranging from 102.5 to 121.6 per 100,000. Notably, although Black women had lower crude mortality than White women, they exhibited higher rates of heart failure and acute myocardial infarction compared to Hispanic and Asian populations. Asian women consistently had the lowest rates, ranging from 47.3 to 59.2 per 100,000 women, with particularly low rates of ischemic and atherosclerotic heart disease, as shown in Table 7 and Table 8. In Table 7, it is seen that White women had the highest burden of disease across all years, with crude mortality for diseases of the heart ranging from 174.0 to 187.9 per 100,000. Within Table 9 and Table 10, Native American and Other Race categories displayed variable rates, but estimates were limited by small sample sizes and frequent data suppression, especially in subcategories such as acute endocarditis or pericardial disease. These patterns point to persistent racial differences in CVD mortality and emphasize the need for targeted public health interventions that act on upstream determinants of cardiovascular risk.

3. Discussion

This descriptive study examines trends in heart disease mortality among US women aged 35 and older residing in Florida. By analyzing mortality data, significant patterns, barriers to care, and areas of concern within this population were identified, which in turn will guide and inform the development of evidence-based interventions focused on addressing the specific needs of US adult women at high risk of dying from CVD. Ultimately, such critical prevention and early intervention efforts will enhance the implementation of comprehensive public health strategies and cardiovascular health outcomes across Florida.
Our findings show a clear disproportionate burden faced by older populations within the gradient of CVD-related mortality, particularly among women aged 35 and older. According to the American Heart Association (AHA), the incidence of CVD among US women rises sharply with age, affecting approximately 40% of women aged 40 to 59, 75% aged 60 to 79, and nearly 86% over the age of 80 [28,29]. While men under the age of 40 show higher CVD prevalence compared to women, rates equalize by age 40 to 60, and rates are then surpassed when compared to older women over the age of 60 [30]. Despite overall improvements in male CVD mortality over the past decade, women have experienced an opposite trend, with mortality rates increasing [30]. More women die each year from CVD, especially post-menopause, a reality that remains underappreciated by many healthcare providers [28,30]. Additionally, the highest attributable rate of CVD deaths has been linked to ischemic heart disease, peripheral artery disease, and stroke [31,32,33,34].
Aside from age, other risk factors, such as the growing incidence of obesity, metabolic syndrome, and diabetes, continue to rise alongside CVD in the US [28,30]. Studies demonstrate that women with diabetes face a 44% higher relative risk of CVD compared to men, and obesity increases their risk by 64% versus 46% in men [35]. Similar findings have been seen regarding hyperlipidemia; however, despite evidence supporting the efficacy of statins in reducing dyslipidemia, women remain less likely than men to receive these treatments, which emphasizes the need for greater clinical awareness and proactive efforts to identify and manage CVD among female patients [30,35]. Emerging evidence also links psychosocial factors such as loneliness and social isolation to increased CVD risk, as it could potentially lead to hypertension, dyslipidemia, obesity, smoking use, physical inactivity, and poor dietary habits [36,37].
Additional findings from our study consistently demonstrated that non-Hispanic populations were at significantly higher risk of CVD-related deaths compared to Hispanic populations. Non-Hispanic women had nearly double the crude mortality rate for ischemic heart disease compared to Hispanic women. Acute myocardial infarction, other chronic ischemic heart disease, and heart failure all followed similar patterns. CVD presents a disproportionately higher risk of mortality among racial and ethnic minority groups in the US [38,39]. It is the leading cause of death for both African American and non-Hispanic White women and the second leading cause among non-White Hispanic and Asian or Pacific Islander women [38,39]. To emphasize, CVD claims the lives of nearly 50,000 African American women annually, with approximately 60% of these non-Hispanic Black women being over the age of 20. Although our analysis shows higher rates of CVD among non-Hispanic populations, the demographic composition of Florida may influence this. In addition, our findings might indicate a gap in CVD-reported mortalities in Hispanic populations in the state. Hispanic women exhibit around 20% lower CVD mortality rates compared to non-Hispanic women [39,40]. However, this observation may overlook the wide range of racial, ethnic, and socioeconomic backgrounds within the Hispanic/Latino population of the US [39,40,41]. For instance, research typically relies on cross-sectional studies that either focus narrowly on Mexican Americans or aggregate diverse Hispanic subgroups together [39,40]. These limitations may contribute to underreporting or gaps in accurately capturing CVD-related mortality within Hispanic populations in Florida.
In our study, White women had the highest burden of CVD across all years, followed by Black women. Although Black women had a lower crude mortality rate than White women, they exhibited higher rates of CVD-related conditions, such as heart failure and acute myocardial infarction compared to Hispanic and Asian populations. This is consistent with evidence that affirms that while Black women may have lower mortality rates related to cardiovascular disease, they often experience an increased level of severity associated with these conditions [39,40,41]. Additional studies have shown that gaps in prevention, later detection, and interventions that are not culturally tailored, particularly in minority groups, contribute to these differences in CVD outcomes [41,42]. While White women have higher rates of CVD in Florida and across the United States, more efforts are needed to improve awareness on protective behaviors to prevent CVD deaths.
Existing evidence-based educational and lifestyle interventions for CVD such as health education sessions in primary care settings, community-based programs, and digital health technologies have shown to improve factors that affect cardiovascular health directly and indirectly [43,44]. These interventions have effectively improved physical activity, dietary habits, and cardiovascular risk profiles [44]. However, significant gaps remain in reaching and engaging high-risk and diverse communities [45,46,47]. Evidence has shown that only a small percentage of individuals adhere to recommended lifestyle modifications, and these numbers decrease in ethnically marginalized populations [48]. Therefore, patient education that is culturally adapted by incorporating languages, values, and community specific needs has been shown to improve self-care, knowledge, and health outcomes in these minority groups [45,46,47,48]. Although there is a relatively adequate baseline knowledge of risk factors in older populations, there are gaps that persist regarding specific preventive measures [48,49]. Thus, educational efforts must emphasize the benefits of maintaining a healthy lifestyle, which includes moderate physical activity, Mediterranean or plant-based diet, and smoking cessation [48,49,50]. Such interventions must be optimized to allow for adaptation to cultural and structural contexts, allowing them to address the unique needs of high-risk and historically marginalized groups [46,48,50].

Limitations

The utilization of the CDC WONDER database, while allowing for access to many data points throughout the US, also limits the generalizability of this analysis. Because CDC WONDER uses aggregate-level data, providing an overarching dataset for populations, this limits our ability to analyze data at the individual level. Additionally, this restricts the use of multi-variate analysis. In an effort to protect participant privacy, smaller datasets are suppressed (sets of 10 or fewer), which limits state- and county-level data analysis and suppresses rare findings. CDC WONDER provides little data on sociodemographic variables such as education, insurance status, and comorbidities, which limits this analysis’s ability to adjust for confounding variables. Lastly, data from CDC WONDER relies on categorization by ICD code, which varies among regions and providers. This may contribute to misclassification of diagnoses or causes of death when combining data from multiple categorization methods.

4. Materials and Methods

4.1. Methods

The Wide-ranging Online Data for Epidemiologic Research (WONDER) is an easily accessible method for public health professionals and the general public to explore the vast public health information of the Centers for Disease Control and Prevention (CDC) [51]. The CDC WONDER database encourages public health research, informed decision making, and simplified access to detailed information from the CDC for the general public [51]. A wide array of public health data sets are available and are classified into two categories: CDC WONDER Online Databases and Other Data Collections. The CDC WONDER Online Databases includes information regarding AIDS public information data, natality, cancer statistics, mortality, environmental data, population estimates, sexually transmitted disease morbidity, tuberculosis, and vaccine adverse events [52]. Other Data Collections hosted on CDC WONDER include Healthy People 2010 data, national notifiable diseases, and influenza bioinformatics [52]. Each data set typically includes additional information such as age, sex, race/ethnicity, year, and geographic location. However, the database does not provide individual-level data, small data values, non-U.S./U.S. territories data, or real-time updated data.

4.2. Study Design and Population

This study analyzed underlying causes of cardiovascular deaths using death certificate data from the CDC WONDER database from the years 2018–2023 and stratified the data by single race categories in the State of Florida [53]. The primary focus was to examine mortality trends for ischemic heart disease (ICD I20–I25) and other forms of heart diseases (ICD I30–I51) for female adults aged 35 years and older. Data was stratified by ten-year age groups, Hispanic origin, race category, and all places of death and urbanization levels in the state of Florida. A secondary focus was to examine mortality trends using the ICD-10 113 cause list for major cardiovascular disease (I00–I78), including hypertensive heart disease (I11), acute myocardial infarction (I21–I22), and heart failure (I50), among others. Since the dataset is publicly accessible and de-identified, the study did not require institutional review board approval. The study followed the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines [54].

4.3. Data Collection

Data was extracted and categorized based on demographic variables such as ten-year age groups, gender, race/ethnicity, urbanization, state, educational levels, autopsy, and place of death. Ten-year age groups included 35–44, 45–54, 55–64, 65–74, 75–84, and 85+ years old. Only females were selected as this was the population group of interest. Florida was selected as the sole location of interest, with all 2013 categories for urbanization including large central metro, large fringe metro, medium metro, small metro, micropolitan, and noncore. Races included White, Black or African American, Asian, American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, and more than one race. Ethnicity was classified as Hispanic or non-Hispanic. The locations of death included homes, nursing or long-term care facilities, medical facilities, hospices, and other unclassified locations.

4.4. Statistical Analysis

The study assessed mortality trends across a five-year period from 2018–2023 for major cardiovascular diseases in US female adults aged ≥35 years old and residing in the state of Florida, considering variables such as race, age, and ethnicity. Stratification was also carried out by CVD subtype to analyze specific mortality trends by underlying cause of CVD deaths. Crude and age-adjusted mortality rates (AAMRs) per 100,000 individuals were calculated, using the 2000 US population as the standard for AAMR. Total percentages in cardiovascular mortality across years were calculated.

5. Conclusions

This analysis aimed to identify differences and patterns among women aged 35 and older at risk of dying from CVD. Using the CDC WONDER database, national data of women dying from cardiovascular causes was analyzed for detection of these patterns. This analysis identified a greater burden of cardiovascular death among women older than 35, Hispanic populations, and White and Black individuals. These results highlight the need for focused interventions that are beneficial in lowering rates of cardiovascular deaths in these populations that are disproportionately affected.

Author Contributions

Conceptualization, A.P. and L.S.; methodology, A.P.; software, A.P.; validation, D.L. and L.S.; formal analysis, A.P.; investigation, A.P., A.R., D.L., M.S., V.J. and S.K.; resources, A.P.; data curation, A.P.; writing—original draft preparation, A.P., A.R., D.L., M.S., V.J. and S.K.; writing—review and editing, L.S.; visualization, L.S.; supervision, L.S.; project administration, L.S.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The authors used data from a national public dataset, the CDC WONDER database for year 2018–2021, and can share the specific dataset used upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Heart Disease Remains Leading Cause of Death as Key Health Risk Factors Continue to Rise. American Heart Association. Available online: https://newsroom.heart.org/news/heart-disease remains-leading-cause-of-death-as-key-health-risk-factors-continue-to-rise (accessed on 14 July 2025).
  2. Centers for Disease Control and Prevention. Heart Disease Facts. Available online: https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html (accessed on 14 July 2025).
  3. Lui, J.N.M.; Williams, C.; Keng, M.J.; Hopewell, J.C.; Sammons, E.; Chen, F.; Gray, A.; Bowman, L.; Landray, S.S.M.J.; Mihaylova, B.; et al. Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People with Cardiovascular Disease in the United Kingdom and United States. J. Am. Heart Assoc. 2023, 12, e030766. [Google Scholar] [CrossRef]
  4. Teshale, A.B.; Htun, H.L.; Owen, A.; Gasevic, D.; Phyo, A.Z.Z.; Fancourt, D.; Ryan, J.; Steptoe, A.; Freak-Poli, R. The Role of Social Determinants of Health in Cardiovascular Diseases: An Umbrella Review. J. Am. Heart Assoc. 2023, 12, e029765. [Google Scholar] [CrossRef] [PubMed]
  5. Prabakaran, S.; Schwartz, A.; Lundberg, G. Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: Risks, benefits, and current guidelines for use. Ther. Adv. Endocrinol. Metab. 2021, 12, 20420188211013917. [Google Scholar] [CrossRef]
  6. Schwalm, J.D.; McKee, M.; Huffman, M.D.; Yusuf, S. Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation 2016, 133, 742–755. [Google Scholar] [CrossRef]
  7. Zhang, Y. Cardiovascular diseases in American women. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 386–393. [Google Scholar] [CrossRef]
  8. Martin, S.S.; Aday, A.W.; Allen, N.B.; Almarzooq, Z.I.; Anderson, C.A.; Arora, P.; Avery, C.L.; Baker-Smith, C.M.; Bansal, N.; Beaton, A.Z.; et al. 2025 Heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation 2025, 151, e41–e660. [Google Scholar]
  9. Mensah, G.A.; Wei, G.S.; Sorlie, P.D.; Fine, L.J.; Rosenberg, Y.; Kaufmann, P.G.; Mussolino, M.E.; Hsu, L.L.; Addou, E.; Engelgau, M.M.; et al. Decline in Cardiovascular Mortality: Possible Causes and Implications. Circ. Res. 2017, 120, 366–380. [Google Scholar] [CrossRef] [PubMed]
  10. Young, L.; Cho, L. Unique cardiovascular risk factors in women. Heart 2019, 105, 1656–1660. [Google Scholar] [CrossRef]
  11. Bybee, K.A.; Stevens, T.L. Matters of the heart: Cardiovascular disease in U.S. women. Mo. Med. 2013, 110, 65–70. [Google Scholar] [PubMed]
  12. Mayo Foundation for Medical Education and Research. Heart Disease in Women: Understand Symptoms and Risk Factors. Mayo Clinic. 25 October 2024. Available online: https://www.mayoclinic.org/diseases-conditions/heart-disease/in-depth/heart-disease/art-20046167 (accessed on 18 July 2025).
  13. Florida Department of Health. Deaths from Heart Diseases—FL Health Charts—Florida Department of Health. FL Health Charts. Available online: https://www.flhealthcharts.gov/ChartsDashboards/rdPage.aspx?rdReport=Death.DataViewer&cid=0098 (accessed on 19 July 2025).
  14. Heart Disease. Heart Disease|Florida Department of Health. Available online: https://www.floridahealth.gov/diseases-and-conditions/heart-disease/index.html#:~:text=Heart%20disease%20accounts%20for%20approximately%202%20out,heart%20attack%2C%20corresponding%20approximately%20to%20902%2C42%20individuals (accessed on 20 July 2025).
  15. Cho, L.; Davis, M.; Elgendy, I.; Epps, K.; Lindley, K.J.; Mehta, P.K.; Michos, E.D.; Minissian, M.; Pepine, C.; Vaccarino, V.; et al. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. JACC 2020, 75, 2602–2618. [Google Scholar] [CrossRef]
  16. Garcia, M.; Mulvagh, S.L.; Merz, C.N.; Buring, J.E.; Manson, J.E. Cardiovascular Disease in Women: Clinical Perspectives. Circ. Res. 2016, 118, 1273–1293. [Google Scholar] [CrossRef]
  17. Mieres, J.H.; Heller, G.V.; Hendel, R.C.; Gulati, M.; Boden, W.E.; Katten, D.; Shaw, L.J. Signs and symptoms of suspected myocardial ischemia in women: Results from the what is the optimal method for ischemia evaluation in women? Trial. J. Womens Health 2011, 20, 1261–1268. [Google Scholar] [CrossRef]
  18. Akhabue, E.; Rua, M.; Gandhi, P.; Kim, J.H.; Cantor, J.C.; Setoguchi, S. Disparate Cardiovascular Hospitalization Trends Among Young and Middle-Aged Adults Within and Across Race and Ethnicity Groups in Four States in the United States. J. Am. Heart Assoc. 2023, 12, e7978. [Google Scholar] [CrossRef]
  19. Institute for Health Metrics and Evaluation. Social Determinants of Health and Cardiovascular Disease: State of the Evidence. Available online: https://www.healthdata.org/sites/default/files/2024-08/SDH%20CVD%20Evidence%20Report.pdf (accessed on 21 July 2025).
  20. Carnethon, M.R.; Pu, J.; Howard, G.; Albert, M.A.; Anderson, C.A.; Bertoni, A.G.; Mujahid, M.S.; Palaniappan, L.; Taylor, H.A., Jr.; Willis, M.; et al. Cardiovascular health in African Americans: A scientific statement from the American Heart Association. Circulation 2017, 136, e393–e423. [Google Scholar] [CrossRef] [PubMed]
  21. Chahal, C.A.A.; Alahdab, F.; Asatryan, B.; Addison, D.; Aung, N.; Chung, M.K.; Denaxas, S.; Dunn, J.; Hall, J.L.; Pamir, N.; et al. Data Interoperability and Harmonization in Cardiovascular Genomic and Precision Medicine. Circ. Genom. Precis. Med. 2025, 18, e004624. [Google Scholar] [CrossRef]
  22. McNamara, D. Residential Block Greenness Linked to Lower Incidence of Six Cardiovascular Conditions. InventUM. 15 October 2024. Available online: https://news.med.miami.edu/residential-block-greenness-linked-to-cardiovascular-health/ (accessed on 22 July 2025).
  23. Keith, R.J.; Hart, J.L.; Bhatnagar, A. Greenspaces and Cardiovascular Health. Circ. Res. 2024, 134, 1179–1196. [Google Scholar] [CrossRef]
  24. Mosca, L.; Mochari, H.; Christian, A.; Berra, K.; Taubert, K.; Mills, T.; Burdick, K.A.; Simpson, S.L. National study of women’s awareness, preventive action, and barriers to cardiovascular health. Circulation 2006, 113, 525–534. [Google Scholar] [CrossRef] [PubMed]
  25. Tobb, K.; Kocher, M.; Bullock-Palmer, R.P. Underrepresentation of women in cardiovascular trials- it is time to shatter this glass ceiling. Am. Heart J. Plus 2022, 13, 100109. [Google Scholar] [CrossRef] [PubMed]
  26. Bairey Merz, C.; Andersen, H.; Sprague, E.; Burns, A.; Keida, M.; Walsh, M.N.; Greenberger, P.; Campbell, S.; Pollin, I.; McCullough, C.; et al. Knowledge, Attitudes, and Beliefs Regarding Cardiovascular Disease in Women: The Women’s Heart Alliance. JACC 2017, 70, 123–132. [Google Scholar] [CrossRef]
  27. Brandt, E.J.; Tobb, K.; Cambron, J.C.; Ferdinand, K.; Douglass, P.; Nguyen, P.K.; Vijayaraghavan, K.; Islam, S.; Thamman, R.; Rahman, S.; et al. Assessing and Addressing Social Determinants of Cardiovascular Health: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2023, 81, 1368–1385. [Google Scholar] [CrossRef]
  28. Rodgers, J.L.; Jones, J.; Bolleddu, S.I.; Vanthenapalli, S.; Rodgers, L.E.; Shah, K.; Karia, K.; Panguluri, S.K. Cardiovascular Risks Associated with Gender and Aging. J. Cardiovasc. Dev. Dis. 2019, 6, 19. [Google Scholar] [CrossRef]
  29. Yazdayar, A.; Newman, A.B. The Burden of Cardiovascular Disease in the Elderly: Morbidity, Mortality, and Costs. Clin. Geriatr. Med. 2009, 25, 563–577. [Google Scholar] [CrossRef] [PubMed]
  30. Mankad, R.; Best, P.J. Cardiovascular Disease in Older Women: A Challenge in Diagnosis and Treatment. Womens Health 2008, 4, 449–464. [Google Scholar] [CrossRef] [PubMed]
  31. Vervoort, D.; Wang, R.; Li, G.; Filbey, L.; Maduka, O.; Brewer, L.C.; Mamas, M.A.; Bahit, M.C.; Ahmed, S.B.; Van Spall, H.G. Addressing the Global Burden of Cardiovascular Disease in Women. J. Am. Coll. Cardiol. 2024, 83, 2690–2707. [Google Scholar] [CrossRef]
  32. Wang, L.Y.T.; Chiang, G.S.H.; Wee, C.F.; Chan, S.W.K.; Lau, J.X.X.; Taeihagh, A. Preventing ischemic heart disease in women: A systematic review of global directives and policies. npj Womens Health 2024, 2, 36. [Google Scholar] [CrossRef]
  33. Bayoumi, E.; Karasik, P. Cardiovascular Disease in Older Women. Clin. Geriatr. Med. 2021, 37, 651–665. [Google Scholar] [CrossRef] [PubMed]
  34. Golaszewski, N.M.; LaCroix, A.Z.; Godino, J.G.; Allison, M.A.; Manson, J.E.; King, J.J.; Weitlauf, J.C.; Bea, J.W.; Garcia, L.; Kroenke, C.H.; et al. Evaluation of Social Isolation, Loneliness, and Cardiovascular Disease Among Older Women in the US. JAMA Netw. Open 2022, 5, e2146461. [Google Scholar] [CrossRef]
  35. Zhang, Y.B.; Chen, C.; Pan, X.F.; Guo, J.; Li, Y.; Franco, O.H.; Liu, G.; Pan, A. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: Two prospective cohort studies. BMJ 2021, 373, n604. [Google Scholar] [CrossRef]
  36. Brown, R.M.; Tamazi, S.; Weinberg, C.R.; Dwivedi, A.; Mieres, J.H. Racial Disparities in Cardiovascular Risk and Cardiovascular Care in Women. Curr. Cardiol. Rep. 2022, 24, 1197–1208. [Google Scholar] [CrossRef]
  37. Mehta, L.S.; Velarde, G.P.; Lewey, J.; Sharma, G.; Navas-Acien, A.; Fretts, A.M.; Magwood, G.S.; Yang, E.; Blumenthal, R.S.; Brown, R.-M.; et al. Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement from the American Heart Association. Circulation 2023, 147, 1471–1487. [Google Scholar] [CrossRef]
  38. Quesada, O.; Crousillat, D.; Rodriguez, F.; Bravo-Jaimes, K.; Briller, J.; Ogunniyi, M.O.; Mattina, D.J.; Aggarwal, N.R.; Rodriguez, C.J.; De Oliveira, G.M.M.; et al. Cardiovascular Disease in Hispanic Women: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2024, 83, 1702–1712. [Google Scholar] [CrossRef]
  39. Breathett, K.; Manson, J.E. Priority for Cardiovascular Health Equity Among U.S. Women: The Need for a Greater Emphasis on Social Determinants of Health. Available online: https://professional.heart.org/en/science-news/cardiovascular-disease-risk-factors-in-women-impact-of-race/commentary (accessed on 13 June 2025).
  40. Gomez, S.; Blumer, V.; Rodriguez, F. Unique Cardiovascular Disease Risk Factors in Hispanic Individuals. Curr. Cardiovasc. Risk Rep. 2022, 16, 53–61. [Google Scholar] [CrossRef]
  41. Ogunniyi, M.O.; Mahmoud, Z.; Commodore-Mensah, Y.; Fleg, J.L.; Fatade, Y.A.; Quesada, O.; Aggarwal, N.R.; Mattina, D.J.; De Oliveira, G.M.M.; Lindley, K.J.; et al. Eliminating Disparities in Cardiovascular Disease for Black Women. J. Am. Coll. Cardiol. 2022, 80, 1762–1771. [Google Scholar] [CrossRef]
  42. Velarde, G.; Bravo-Jaimes, K.; Brandt, E.J.; Wang, D.; Douglass, P.; Castellanos, L.R.; Rodriguez, F.; Palaniappan, L.; Ibebuogu, U.; Bond, R.; et al. Locking the Revolving Door: Racial Disparities in Cardiovascular Disease. J. Am. Heart Assoc. 2023, 12, e025271. [Google Scholar] [CrossRef]
  43. Govori, V.; Budinčević, H.; Morović, S.; Đerke, F.; Demarin, V. Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review. Medicina 2024, 60, 504. [Google Scholar] [CrossRef] [PubMed]
  44. Rippe, J.M. Lifestyle Strategies for Risk Factor Reduction, Prevention, and Treatment of Cardiovascular Disease. Am. J. Lifestyle Med. 2019, 13, 204–212. [Google Scholar] [CrossRef]
  45. Kandula, N.R.; Khurana, N.R.; Makoul, G.; Glass, S.; Baker, D.W. A Community and Culture-Centered Approach to Developing Effective Cardiovascular Health Messages. J. Gen. Intern Med. 2012, 27, 1308–1316. [Google Scholar] [CrossRef]
  46. Moise, N.; Cené, C.W.; Tabak, R.G.; Young, D.R.; Mills, K.T.; Essien, U.R.; Anderson, C.A.; Lopez-Jimenez, F.; American Heart Association Council on Epidemiology and Prevention. Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement from the American Heart Association. Circulation 2022, 146, e260–e278. [Google Scholar] [CrossRef] [PubMed]
  47. Sakr, F.; Safwan, J.; Cherfane, M.; Salameh, P.; Sacre, H.; Haddad, C.; El Khatib, S.; Rahal, M.; Dia, M.; Harb, A.; et al. Knowledge and Awareness of Stroke among the Elderly Population: Analysis of Data from a Sample of Older Adults in a Developing Country. Medicina 2023, 59, 2172. [Google Scholar] [CrossRef] [PubMed]
  48. Ramôa Castro, A.; Oliveira, N.L.; Ribeiro, F.; Oliveira, J. Impact of educational interventions on primary prevention of cardiovascular disease: A systematic review with a focus on physical activity. Eur. J. Gen. Pract. 2017, 23, 59–68. [Google Scholar] [CrossRef] [PubMed]
  49. Gohlke, H. Is it worth offering cardiovascular disease prevention to the elderly? Eur. J. Prev. Cardiol. 2013, 20, 121–126. [Google Scholar] [CrossRef] [PubMed]
  50. Pearson, T.A.; Peters, T.D. The Treatment Gap in Coronary Artery Disease and Heart Failure: Community Standards and the Post-Discharge Patient. Am. J. Cardiol. 1997, 80, 45H–52H. [Google Scholar] [CrossRef] [PubMed]
  51. General Help for CDC WONDER. 10 June 2025. Available online: https://wonder.cdc.gov/wonder/help/main.html#WhatisWONDER (accessed on 12 June 2025).
  52. Data Summary Descriptions. 10 June 2025. Available online: https://wonder.cdc.gov/datasets.html (accessed on 12 June 2025).
  53. CDCWONDER. Available online: https://wonder.cdc.gov/ (accessed on 13 June 2025).
  54. STROBE. Available online: https://www.strobe-statement.org/ (accessed on 13 June 2025).
Women 05 00037 g001
Figure 1. Trends in Age-Adjusted CVD-Related Deaths Among US Women in Florida Aged ≥35 Years for 2018–2023.
Figure 1. Trends in Age-Adjusted CVD-Related Deaths Among US Women in Florida Aged ≥35 Years for 2018–2023.
Women 05 00037 g001
Table 1. Percentage of Total Cardiovascular-Related Deaths and Ten-Year Age-Adjusted Crude Rates for US Women Residing in Florida and Aged ≥35 years old.
Table 1. Percentage of Total Cardiovascular-Related Deaths and Ten-Year Age-Adjusted Crude Rates for US Women Residing in Florida and Aged ≥35 years old.
YearTen-Year Age GroupDeathsPopulationCrude Rate (95% CI)% of Total Deaths
201835–44 years1421,294,98111 (95% CI: 9.2–12.8)0.10%
45–54 years4371,399,68931.2 (95% CI: 28.3–34.1)0.40%
55–64 years12931,503,80186 (95% CI: 81.3–90.7)1.20%
65–74 years24711,290,361191.5 (95% CI: 183.9–199)2.30%
75–84 years4277758,332564 (95% CI: 547.1–580.9)3.90%
85+ years9318344,1342707.7 (95% CI: 2652.7–2762.6)8.60%
201935–44 years1441,309,91511 (95% CI: 9.2–12.8)0.10%
45–54 years3701,381,41726.8 (95% CI: 24.1–29.5)0.30%
55–64 years12591,523,36282.6 (95% CI: 78.1–87.2)1.20%
65–74 years24901,328,810187.4 (95% CI: 180–194.7)2.30%
75–84 years4407792,273556.2 (95% CI: 539.8–572.7)4.10%
85+ years9192347,1832647.6 (95% CI: 2593.5–2701.7)8.50%
202035–44 years1481,331,45911.1 (95% CI: 9.3–12.9)0.10%
45–54 years3711,372,75727 (95% CI: 24.3–29.8)0.30%
55–64 years13051,543,27884.6 (95% CI: 80–89.1)1.20%
65–74 years26591,371,149193.9 (95% CI: 186.6–201.3)2.50%
75–84 years4536821,488552.2 (95% CI: 536.1–568.2)4.20%
85+ years9360354,1502642.9 (95% CI: 2589.4–2696.5)8.60%
202135–44 years1361,352,71210.1 (95% CI: 8.4–11.7)0.10%
45–54 years4031,362,91529.6 (95% CI: 26.7–32.5)0.40%
55–64 years13311,540,94286.4 (95% CI: 81.7–91)1.20%
65–74 years27831,386,887200.7 (95% CI: 193.2–208.1)2.60%
75–84 years4646800,710580.2 (95% CI: 563.6–596.9)4.30%
85+ years8911317,2032809.2 (95% CI: 2750.9–2867.6)8.20%
202235–44 years1231,377,8118.9 (95% CI: 7.3–10.5)0.10%
45–54 years3841,368,42928.1 (95% CI: 25.3–30.9)0.40%
55–64 years12431,540,46780.7 (95% CI: 76.2–85.2)1.10%
65–74 years26331,394,908188.8 (95% CI: 181.5–196)2.40%
75–84 years4650869,802534.6 (95% CI: 519.2–550)4.30%
85+ years8864365,3662426.1 (95% CI: 2375.6–2476.6)8.20%
202335–44 years1401,428,2329.8 (95% CI: 8.2–11.4)0.10%
45–54 years3611,394,71525.9 (95% CI: 23.2–28.6)0.30%
55–64 years12081,562,47577.3 (95% CI: 73–81.7)1.10%
65–74 years25951,432,877181.1 (95% CI: 174.1–188.1)2.40%
75–84 years4800905,527530.1 (95% CI: 515.1–545.1)4.40%
85+ years8448343,8972456.5 (95% CI: 2404.2–2508.9)7.80%
2018–202335–44 years8338,095,11010.3 (95% CI: 9.6–11)0.80%
45–54 years23268,279,92228.1 (95% CI: 27–29.2)2.10%
55–64 years76399,214,32582.9 (95% CI: 81–84.8)7.10%
65–74 years156318,204,992190.5 (95% CI: 187.5–193.5)14.40%
75–84 years273164,948,132552 (95% CI: 545.5–558.6)25.20%
85+ years540932,071,9332610.8 (95% CI: 2588.7–2632.8)49.90%
Table 2. Cardiovascular Deaths and Hispanic-Ethnicity-Adjusted Crude Rates for US Women Aged ≥35 years old in Florida.
Table 2. Cardiovascular Deaths and Hispanic-Ethnicity-Adjusted Crude Rates for US Women Aged ≥35 years old in Florida.
Hispanic OriginYear
201820192020202120222023
DeathsPopCRDeathsPopCRDeathsPopCRDeathsPopCRDeathsPopCRDeathsPopCR
Hispanic Origin24712,816,36487.7 (95% CI: 84.3–91.2)24512,866,97285.5 (95% CI: 82.1–88.9)27172,910,34193.4 (95% CI: 89.8–96.9)25792,934,42787.9 (95% CI: 84.5–91.3)25363,024,03883.9 (95% CI: 80.6–87.1)25003,116,04580.2 (95% CI: 77.1–83.4)
Not Hispanic Origin15,5278,071,184192.4 (95% CI: 189.3–195.4)15,4888,113,709190.9 (95% CI: 187.9–193.9)15,7448,202,791191.9 (95% CI: 188.9–194.9)15,7148,136,344193.1 (95% CI: 190.1–196.2)15,4258,275,359186.4 (95% CI: 183.5–189.3)15,1128,385,872180.2 (95% CI: 177.3–183.1)
Table 3. ICD-10 113 Cause List for Cardiovascular Deaths in US Women Aged ≥35 years old in the State of Florida.
Table 3. ICD-10 113 Cause List for Cardiovascular Deaths in US Women Aged ≥35 years old in the State of Florida.
ICD-10 113 Cause ListYear
201820192020202120222023
DeathsPopCRDeathsPopCRDeathsPopulationCRDeathsPopCRDeathsPopCRDeathsPopCR
Major cardiovascular diseases (I00–I78)18,02210,887,548165.5 (95% CI: 163.1–167.9)17,94110,980,681163.4 (95% CI: 161–165.8)18,46511,113,132166.2 (95% CI: 163.8–168.6)18,29911,070,771165.3 (95% CI: 162.9–167.7)17,96411,299,397159 (95% CI: 156.7–161.3)17,61511,501,917153.1 (95% CI: 150.9–155.4)
Diseases of heart (I00–I09,I11,I13,I20–I51)18,02210,887,548165.5 (95% CI: 163.1–167.9)17,94110,980,681163.4 (95% CI: 161–165.8)18,46511,113,132166.2 (95% CI: 163.8–168.6)18,29911,070,771165.3 (95% CI: 162.9–167.7)17,96411,299,397159 (95% CI: 156.7–161.3)17,61511,501,917153.1 (95% CI: 150.9–155.4)
Ischemic heart diseases (I20–I25)12,07810,887,548110.9 (95% CI: 109–112.9)12,07110,980,681109.9 (95% CI: 108–111.9)12,72611,113,132114.5 (95% CI: 112.5–116.5)12,48811,070,771112.8 (95% CI: 110.8–114.8)12,24211,299,397108.3 (95% CI: 106.4–110.3)11,67611,501,917101.5 (95% CI: 99.7–103.4)
Acute myocardial infarction (I21–I22)306010,887,54828.1 (95% CI: 27.1–29.1)287810,980,68126.2 (95% CI: 25.3–27.2)312711,113,13228.1 (95% CI: 27.2–29.1)313311,070,77128.3 (95% CI: 27.3–29.3)300911,299,39726.6 (95% CI: 25.7–27.6)285911,501,91724.9 (95% CI: 23.9–25.8)
Other acute ischemic heart diseases (I24)8210,887,5480.8 (95% CI: 0.6–0.9)9910,980,6810.9 (95% CI: 0.7–1.1)7611,113,1320.7 (95% CI: 0.5–0.9)9111,070,7710.8 (95% CI: 0.7–1)9311,299,3970.8 (95% CI: 0.7–1)9211,501,9170.8 (95% CI: 0.6–1)
Other forms of chronic ischemic heart disease (I20,I25)893610,887,54882.1 (95% CI: 80.4–83.8)909410,980,68182.8 (95% CI: 81.1–84.5)952311,113,13285.7 (95% CI: 84–87.4)926411,070,77183.7 (95% CI: 82–85.4)914011,299,39780.9 (95% CI: 79.2–82.5)872511,501,91775.9 (95% CI: 74.3–77.4)
Atherosclerotic cardiovascular disease, so described (I25.0)171310,887,54815.7 (95% CI: 15–16.5)192110,980,68117.5 (95% CI: 16.7–18.3)226511,113,13220.4 (95% CI: 19.5–21.2)227511,070,77120.5 (95% CI: 19.7–21.4)229011,299,39720.3 (95% CI: 19.4–21.1)231711,501,91720.1 (95% CI: 19.3–21)
All other forms of chronic ischemic heart disease (I20,I25.1–I25.9)722310,887,54866.3 (95% CI: 64.8–67.9)717310,980,68165.3 (95% CI: 63.8–66.8)725811,113,13265.3 (95% CI: 63.8–66.8)698911,070,77163.1 (95% CI: 61.7–64.6)685011,299,39760.6 (95% CI: 59.2–62.1)640811,501,91755.7 (95% CI: 54.3–57.1)
Other heart diseases (I26–I51)594410,887,54854.6 (95% CI: 53.2–56)587010,980,68153.5 (95% CI: 52.1–54.8)573911,113,13251.6 (95% CI: 50.3–53)581111,070,77152.5 (95% CI: 51.1–53.8)572211,299,39750.6 (95% CI: 49.3–52)593911,501,91751.6 (95% CI: 50.3–52.9)
Acute and subacute endocarditis (I33)6810,887,5480.6 (95% CI: 0.5–0.8)4610,980,6810.4 (95% CI: 0.3–0.6)6111,113,1320.5 (95% CI: 0.4–0.7)3811,070,7710.3 (95% CI: 0.2–0.5)4111,299,3970.4 (95% CI: 0.3–0.5)2711,501,9170.2 (95% CI: 0.2–0.3)
Diseases of pericardium and acute myocarditis (I30–I31,I40)2810,887,5480.3 (95% CI: 0.2–0.4)3210,980,6810.3 (95% CI: 0.2–0.4)2311,113,1320.2 (95% CI: 0.1–0.3)4611,070,7710.4 (95% CI: 0.3–0.6)4211,299,3970.4 (95% CI: 0.3–0.5)4811,501,9170.4 (95% CI: 0.3–0.6)
Heart failure (I50)219010,887,54820.1 (95% CI: 19.3–21)214510,980,68119.5 (95% CI: 18.7–20.4)220411,113,13219.8 (95% CI: 19–20.7)225111,070,77120.3 (95% CI: 19.5–21.2)220511,299,39719.5 (95% CI: 18.7–20.3)230211,501,91720 (95% CI: 19.2–20.8)
All other forms of heart disease (I26–I28,I34–I38,I42–I49,I51)365810,887,54833.6 (95% CI: 32.5–34.7)364710,980,68133.2 (95% CI: 32.1–34.3)345111,113,13231.1 (95% CI: 30–32.1)347611,070,77131.4 (95% CI: 30.4–32.4)343411,299,39730.4 (95% CI: 29.4–31.4)356211,501,91731 (95% CI: 30–32)
Table 4. ICD-10 113 Cause List for Cardiovascular Deaths in Hispanic and Non-Hispanic Women Aged ≥35 years old in the State of Florida between the years of 2018–2020.
Table 4. ICD-10 113 Cause List for Cardiovascular Deaths in Hispanic and Non-Hispanic Women Aged ≥35 years old in the State of Florida between the years of 2018–2020.
Year
ICD-10 113 Cause List201820192020
HispanicNon-HispanicHispanicNon-HispanicHispanicNon-Hispanic
DeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude Rate
Major cardiovascular diseases (I00–I78)24712,816,36487.7 (95% CI: 84.3–91.2)15,5278,071,184192.4 (95% CI: 189.3–195.4)24512,866,97285.5 (95% CI: 82.1–88.9)15,4888,113,70927172,910,34193.4 (95% CI: 89.8–96.9)271715,7448,202,791191.9 (95% CI: 188.9–194.9)
Diseases of heart (I00–I09,I11,I13,I20–I51)24712,816,36487.7 (95% CI: 84.3–91.2)15,5278,071,184192.4 (95% CI: 189.3–195.4)24512,866,97285.5 (95% CI: 82.1–88.9)15,4888,113,70927172,910,34193.4 (95% CI: 89.8–96.9)271715,7448,202,791191.9 (95% CI: 188.9–194.9)
Ischemic heart diseases (I20–I25)17462,816,36462 (95% CI: 59.1–64.9)10,3158,071,184127.8 (95% CI: 125.3–130.3)17842,866,97262.2 (95% CI: 59.3–65.1)10,2878,113,70919732,910,34167.8 (95% CI: 64.8–70.8)197310,7508,202,791131.1 (95% CI: 128.6–133.5)
Acute myocardial infarction (I21–I22)5132,816,36418.2 (95% CI: 16.6–19.8)25418,071,18431.5 (95% CI: 30.3–32.7)4932,866,97217.2 (95% CI: 15.7–18.7)23858,113,7096292,910,34121.6 (95% CI: 19.9–23.3)62924988,202,79130.5 (95% CI: 29.3–31.6)
Other acute ischemic heart diseases (I24)112,816,364Unreliable718,071,1840.9 (95% CI: 0.7–1.1)142,866,972Unreliable858,113,709Suppressed2,910,341SuppressedSuppressed678,202,7910.8 (95% CI: 0.6–1)
Other forms of chronic ischemic heart disease (I20,I25)12222,816,36443.4 (95% CI: 41–45.8)77038,071,18495.4 (95% CI: 93.3–97.6)12772,866,97244.5 (95% CI: 42.1–47)78178,113,70913352,910,34145.9 (95% CI: 43.4–48.3)133581858,202,79199.8 (95% CI: 97.6–101.9)
Atherosclerotic cardiovascular disease, so described (I25.0)1352,816,3644.8 (95% CI: 4–5.6)15748,071,18419.5 (95% CI: 18.5–20.5)1582,866,9725.5 (95% CI: 4.7–6.4)17638,113,7092052,910,3417 (95% CI: 6.1–8)20520608,202,79125.1 (95% CI: 24–26.2)
All other forms of chronic ischemic heart disease (I20,I25.1–I25.9)10872,816,36438.6 (95% CI: 36.3–40.9)61298,071,18475.9 (95% CI: 74–77.8)11192,866,97239 (95% CI: 36.7–41.3)60548,113,70911302,910,34138.8 (95% CI: 36.6–41.1)113061258,202,79174.7 (95% CI: 72.8–76.5)
Other heart diseases (I26–I51)7252,816,36425.7 (95% CI: 23.9–27.6)52128,071,18464.6 (95% CI: 62.8–66.3)6672,866,97223.3 (95% CI: 21.5–25)52018,113,7097442,910,34125.6 (95% CI: 23.7–27.4)74449948,202,79160.9 (95% CI: 59.2–62.6)
Acute and subacute endocarditis (I33)Suppressed2,816,364Suppressed598,071,1840.7 (95% CI: 0.6–0.9)Suppressed2,866,972Suppressed418,113,709Suppressed2,910,341SuppressedSuppressed548,202,7910.7 (95% CI: 0.5–0.9)
Diseases of pericardium and acute myocarditis (I30–I31,I40)Suppressed2,816,364Suppressed248,071,1840.3 (95% CI: 0.2–0.4)Suppressed2,866,972Suppressed288,113,709Suppressed2,910,341SuppressedSuppressed208,202,7910.2 (95% CI: 0.1–0.4)
Heart failure (I50)2502,816,3648.9 (95% CI: 7.8–10)19388,071,18424 (95% CI: 22.9–25.1)2222,866,9727.7 (95% CI: 6.7–8.8)19228,113,7092802,910,3419.6 (95% CI: 8.5–10.7)28019238,202,79123.4 (95% CI: 22.4–24.5)
All other forms of heart disease (I26–I28,I34–I38,I42–I49,I51)4632,816,36416.4 (95% CI: 14.9–17.9)31918,071,18439.5 (95% CI: 38.2–40.9)4362,866,97215.2 (95% CI: 13.8–16.6)32108,113,7094542,910,34115.6 (95% CI: 14.2–17)45429978,202,79136.5 (95% CI: 35.2–37.8)
Table 5. ICD-10 113 Cause List for Cardiovascular Deaths in Hispanic and Non-Hispanic Women Aged ≥35 years old in the State of Florida between the years of 2021–2023.
Table 5. ICD-10 113 Cause List for Cardiovascular Deaths in Hispanic and Non-Hispanic Women Aged ≥35 years old in the State of Florida between the years of 2021–2023.
ICD-10 113 Cause ListYear
202120222023
HispanicNon-HispanicHispanicNon-HispanicHispanicNon-Hispanic
Major cardiovascular diseases (I00–I78)DeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude RateDeathPopulationCrude Rate
Diseases of heart (I00–I09,I11,I13,I20–I51)25792,934,42787.9 (95% CI: 84.5–91.3)15,7148,136,344193.1 (95% CI: 190.1–196.2)25363,024,03883.9 (95% CI: 80.6–87.1)15,4258,275,359186.4 (95% CI: 183.5–189.3)25003,116,04580.2 (95% CI: 77.1–83.4)15,1128,385,872180.2 (95% CI: 177.3–183.1)
Ischemic heart diseases (I20–I25)25792,934,42787.9 (95% CI: 84.5–91.3)15,7148,136,344193.1 (95% CI: 190.1–196.2)25363,024,03883.9 (95% CI: 80.6–87.1)15,4258,275,359186.4 (95% CI: 183.5–189.3)25003,116,04580.2 (95% CI: 77.1–83.4)15,1128,385,872180.2 (95% CI: 177.3–183.1)
Acute myocardial infarction (I21–I22)18332,934,42762.5 (95% CI: 59.6–65.3)10,6528,136,344130.9 (95% CI: 128.4–133.4)17963,024,03859.4 (95% CI: 56.6–62.1)10,4438,275,359126.2 (95% CI: 123.8–128.6)17033,116,04554.7 (95% CI: 52.1–57.2)99728,385,872118.9 (95% CI: 116.6–121.2)
Other acute ischemic heart diseases (I24)5822,934,42719.8 (95% CI: 18.2–21.4)25498,136,34431.3 (95% CI: 30.1–32.5)5693,024,03818.8 (95% CI: 17.3–20.4)24408,275,35929.5 (95% CI: 28.3–30.7)5793,116,04518.6 (95% CI: 17.1–20.1)22808,385,87227.2 (95% CI: 26.1–28.3)
Other forms of chronic ischemic heart disease (I20,I25)152,934,427Unreliable768,136,3440.9 (95% CI: 0.7–1.2)143,024,038Unreliable798,275,3591 (95% CI: 0.8–1.2)133,116,045Unreliable798,385,8720.9 (95% CI: 0.7–1.2)
Atherosclerotic cardiovascular disease, so described (I25.0)12362,934,42742.1 (95% CI: 39.8–44.5)80278,136,34498.7 (95% CI: 96.5–100.8)12133,024,03840.1 (95% CI: 37.9–42.4)79248,275,35995.8 (95% CI: 93.6–97.9)11113,116,04535.7 (95% CI: 33.6–37.8)76138,385,87290.8 (95% CI: 88.7–92.8)
All other forms of chronic ischemic heart disease (I20,I25.1–I25.9)2312,934,4277.9 (95% CI: 6.9–8.9)20438,136,34425.1 (95% CI: 24–26.2)1993,024,0386.6 (95% CI: 5.7–7.5)20918,275,35925.3 (95% CI: 24.2–26.4)2093,116,0456.7 (95% CI: 5.8–7.6)21088,385,87225.1 (95% CI: 24.1–26.2)
Other heart diseases (I26–I51)10052,934,42734.2 (95% CI: 32.1–36.4)59848,136,34473.5 (95% CI: 71.7–75.4)10143,024,03833.5 (95% CI: 31.5–35.6)58338,275,35970.5 (95% CI: 68.7–72.3)9023,116,04528.9 (95% CI: 27.1–30.8)55058,385,87265.6 (95% CI: 63.9–67.4)
Acute and subacute endocarditis (I33)7462,934,42725.4 (95% CI: 23.6–27.2)50628,136,34462.2 (95% CI: 60.5–63.9)7403,024,03824.5 (95% CI: 22.7–26.2)49828,275,35960.2 (95% CI: 58.5–61.9)7973,116,04525.6 (95% CI: 23.8–27.4)51408,385,87261.3 (95% CI: 59.6–63)
Diseases of pericardium and acute myocarditis (I30–I31,I40)102,934,427Unreliable288,136,3440.3 (95% CI: 0.2–0.5)Suppressed3,024,038Suppressed358,275,3590.4 (95% CI: 0.3–0.6)Suppressed3,116,045Suppressed258,385,8720.3 (95% CI: 0.2–0.4)
Heart failure (I50)Suppressed2,934,427Suppressed398,136,3440.5 (95% CI: 0.3–0.7)Suppressed3,024,038Suppressed338,275,3590.4 (95% CI: 0.3–0.6)Suppressed3,116,045Suppressed418,385,8720.5 (95% CI: 0.4–0.7)
All other forms of heart disease (I26–I28,I34–I38,I42–I49,I51)2552,934,4278.7 (95% CI: 7.6–9.8)19958,136,34424.5 (95% CI: 23.4–25.6)2683,024,0388.9 (95% CI: 7.8–9.9)19378,275,35923.4 (95% CI: 22.4–24.4)3223,116,04510.3 (95% CI: 9.2–11.5)19798,385,87223.6 (95% CI: 22.6–24.6)
4742,934,42716.2 (95% CI: 14.7–17.6)30008,136,34436.9 (95% CI: 35.6–38.2)4573,024,03815.1 (95% CI: 13.7–16.5)29778,275,35936 (95% CI: 34.7–37.3)4663,116,04515 (95% CI: 13.6–16.3)30958,385,87236.9 (95% CI: 35.6–38.2)
Table 6. ICD-10 113 Cause List for Cardiovascular Deaths for Black Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
Table 6. ICD-10 113 Cause List for Cardiovascular Deaths for Black Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
ICD-10 113 Cause ListYear
Black
201820192020202120222023
DeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude Rate
Diseases of heart (I00–I09,I11,I13,I20–I51)20251,865,163108.6 (103.8–113.3)20171,883,467107.1 (102.4–111.8)23261,912,916121.6 (116.7–126.5)21991,912,527115.0 (110.2–119.8)20401,944,773104.9 (100.3–109.4)20261,977,350102.5 (98.0–106.9)
Acute myocardial infarction (I21–I22)3851,865,16320.6 (18.6–22.7)3501,883,46718.6 (16.6–20.5)4221,912,91622.1 (20.0–24.2)4311,912,52722.5 (20.4–24.7)3751,944,77319.3 (17.3–21.2)3521,977,35017.8 (15.9–19.7)
All other forms of chronic ischemic heart disease (I20,I25.1–I25.9)8021,865,16343.0 (40.0–46.0)7541,883,46740.0 (37.2–42.9)8791,912,91646.0 (42.9–49.0)8391,912,52743.9 (40.9–46.8)7581,944,77339.0 (36.2–41.8)7101,977,35035.9 (33.3–38.5)
All other forms of heart disease (I26–I28,I34–I38,I42–I49,I51)4171,865,16322.4 (20.2–24.5)4161,883,46722.1 (20.0–24.2)4791,912,91625.0 (22.8–27.3)4211,912,52722.0 (19.9–24.1)3931,944,77320.2 (18.2–22.2)4301,977,35021.7 (19.7–23.8)
Atherosclerotic cardiovascular disease, so described (I25.0)1571,865,1638.4 (7.1–9.7)2071,883,46711.0 (9.5–12.5)2491,912,91613.0 (11.4–14.6)2351,912,52712.3 (10.7–13.9)2161,944,77311.1 (9.6–12.6)2421,977,35012.2 (10.7–13.8)
Heart failure (I50)2391,865,16312.8 (11.2–14.4)2601,883,46713.8 (12.1–15.5)2811,912,91614.7 (13.0–16.4)2531,912,52713.2 (11.6–14.9)2781,944,77314.3 (12.6–16.0)2661,977,35013.5 (11.8–15.1)
Ischemic heart diseases (I20–I25)13551,865,16372.6 (68.8–76.5)13291,883,46770.6 (66.8–74.4)15571,912,91681.4 (77.4–85.4)15141,912,52779.2 (75.2–83.1)13601,944,77369.9 (66.2–73.6)13151,977,35066.5 (62.9–70.1)
Major cardiovascular diseases (I00–I78)20251,865,163108.6 (103.8–113.3)20171,883,467107.1 (102.4–111.8)23261,912,916121.6 (116.7–126.5)21991,912,527115.0 (110.2–119.8)20401,944,773104.9 (100.3–109.4)20261,977,350102.5 (98.0–106.9)
Other forms of chronic ischemic heart disease (I20,I25)9591,865,16351.4 (48.2–54.7)9611,883,46751.0 (47.8–54.2)11281,912,91659.0 (55.5–62.4)10741,912,52756.2 (52.8–59.5)9741,944,77350.1 (46.9–53.2)9521,977,35048.1 (45.1–51.2)
Other heart diseases (I26–I51)6701,865,16335.9 (33.2–38.6)6881,883,46736.5 (33.8–39.3)7691,912,91640.2 (37.4–43.0)6851,912,52735.8 (33.1–38.5)6801,944,77335.0 (32.3–37.6)7111,977,35036.0 (33.3–38.6)
Table 7. ICD-10 113 Cause List for Cardiovascular Deaths for White Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
Table 7. ICD-10 113 Cause List for Cardiovascular Deaths for White Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
ICD-10 113 Cause ListYear
White
201820192020202120222023
DeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude Rate
Diseases of heart (I00–I09,I11,I13,I20–I51)15,7538,383,044187.9 (185.0–190.8)15,6668,448,054185.4 (182.5–188.3)15,8978,529,056186.4 (183.5–189.3)15,8198,474,276186.7 (183.8–189.6)15,6228,639,225180.8 (178.0–183.7)15,2688,775,872174.0 (171.2–176.7)
Acute and subacute endocarditis (I33)598,383,0440.7 (0.5–0.9)398,448,0540.5 (0.3–0.6)568,529,0560.7 (0.5–0.9)358,474,2760.4 (0.3–0.6)398,639,2250.5 (0.3–0.6)238,775,8720.3 (0.2–0.4)
Acute myocardial infarction (I21–I22)26368,383,04431.4 (30.2–32.6)24868,448,05429.4 (28.3–30.6)26588,529,05631.2 (30.0–32.3)26538,474,27631.3 (30.1–32.5)25718,639,22529.8 (28.6–30.9)24468,775,87227.9 (26.8–29.0)
All other forms of chronic ischemic heart disease (I20,I25.1–I25.9)63278,383,04475.5 (73.6–77.3)63248,448,05474.9 (73.0–76.7)62738,529,05673.5 (71.7–75.4)60318,474,27671.2 (69.4–73.0)59868,639,22569.3 (67.5–71.0)55768,775,87263.5 (61.9–65.2)
All other forms of heart disease (I26–I28,I34–I38,I42–I49,I51)31818,383,04437.9 (36.6–39.3)31758,448,05437.6 (36.3–38.9)29278,529,05634.3 (33.1–35.6)30118,474,27635.5 (34.3–36.8)29768,639,22534.4 (33.2–35.7)30728,775,87235.0 (33.8–36.2)
Atherosclerotic cardiovascular disease, so described (I25.0)15358,383,04418.3 (17.4–19.2)16838,448,05419.9 (19.0–20.9)19918,529,05623.3 (22.3–24.4)20088,474,27623.7 (22.7–24.7)20438,639,22523.6 (22.6–24.7)20298,775,87223.1 (22.1–24.1)
Diseases of pericardium and acute myocarditis (I30–I31,I40)228,383,0440.3 (0.2–0.4)258,448,0540.3 (0.2–0.4) 378,474,2760.4 (0.3–0.6)358,639,2250.4 (0.3–0.6)368,775,8720.4 (0.3–0.6)
Heart failure (I50)19228,383,04422.9 (21.9–24.0)18548,448,05421.9 (20.9–22.9)19048,529,05622.3 (21.3–23.3)19638,474,27623.2 (22.1–24.2)18928,639,22521.9 (20.9–22.9)20058,775,87222.8 (21.8–23.8)
Ischemic heart diseases (I20–I25)105698,383,044126.1 (123.7–128.5)105738,448,054125.2 (122.8–127.5)109918,529,056128.9 (126.5–131.3)107738,474,276127.1 (124.7–129.5)106808,639,225123.6 (121.3–126.0)101328,775,872115.5 (113.2–117.7)
Major cardiovascular diseases (I00–I78)157538,383,044187.9 (185.0–190.8)156668,448,054185.4 (182.5–188.3)158978,529,056186.4 (183.5–189.3)158198,474,276186.7 (183.8–189.6)156228,639,225180.8 (178.0–183.7)152688,775,872174.0 (171.2–176.7)
Other acute ischemic heart diseases (I24)718,383,0440.8 (0.7–1.1)808,448,0540.9 (0.8–1.2)698,529,0560.8 (0.6–1.0)818,474,2761.0 (0.8–1.2)808,639,2250.9 (0.7–1.2)818,775,8720.9 (0.7–1.1)
Other forms of chronic ischemic heart disease (I20,I25)78628,383,04493.8 (91.7–95.9)80078,448,05494.8 (92.7–96.9)82648,529,05696.9 (94.8–99.0)80398,474,27694.9 (92.8–96.9)80298,639,22592.9 (90.9–95.0)76058,775,87286.7 (84.7–88.6)
Other heart diseases (I26–I51)51848,383,04461.8 (60.2–63.5)50938,448,05460.3 (58.6–61.9)49068,529,05657.5 (55.9–59.1)50468,474,27659.5 (57.9–61.2)49428,639,22557.2 (55.6–58.8)51368,775,87258.5 (56.9–60.1)
Table 8. ICD-10 113 Cause List for Cardiovascular Deaths for Asian Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
Table 8. ICD-10 113 Cause List for Cardiovascular Deaths for Asian Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
ICD-10 113 Cause ListYear
Asian
201820192020202120222023
DeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude Rate
Diseases of heart (I00–I09,I11,I13,I20–I51)161340,05347.3 (40.0–54.7)177341,56651.8 (44.2–59.5)167351,33247.5 (40.3–54.7)235623240.9 (25.9–61.4)207370,65255.8 (48.2–63.5)230388,45359.2 (51.6–66.9)
Acute myocardial infarction (I21–I22)29340,0538.5 (5.7–12.2)28341,5668.2 (5.4–11.8)32351,3329.1 (6.2–12.9)37354,41910.4 (7.4–14.4)48370,65213.0 (9.5–17.2)48388,45312.4 (9.1–16.4)
All other forms of chronic ischemic heart disease (I20,I25.1–I25.9)65340,05319.1 (14.8–24.4)68341,56619.9 (15.5–25.2)70351,33219.9 (15.5–25.2)88354,41924.8 (19.9–30.6)71370,65219.2 (15.0–24.2)79388,45320.3 (16.1–25.3)
All other forms of heart disease (I26–I28,I34–I38,I42–I49,I51)38340,05311.2 (7.9–15.3)38341,56611.1 (7.9–15.3)30351,3328.5 (5.8–12.2)30354,4198.5 (5.7–12.1)43370,65211.6 (8.4–15.6)43388,45311.1 (8.0–14.9)
Atherosclerotic cardiovascular disease, so described (I25.0) 20341,5665.9 (3.6–9.0) 23354,4196.5 (4.1–9.7) 34388,4538.8 (6.1–12.2)
Heart failure (I50) 21341,5666.1 (3.8–9.4) 25354,4197.1 (4.6–10.4)25370,6526.7 (4.4–10.0)25388,4536.4 (4.2–9.5)
Ischemic heart diseases (I20–I25)108340,05331.8 (25.8–37.7)117341,56634.3 (28.0–40.5)121351,33234.4 (28.3–40.6)149354,41942.0 (35.3–48.8)139370,65237.5 (31.3–43.7)161388,45341.4 (35.0–47.8)
Major cardiovascular diseases (I00–I78)161340,05347.3 (40.0–54.7)177341,56651.8 (44.2–59.5)167351,33247.5 (40.3–54.7)205354,41957.8 (49.9–65.8)207370,65255.8 (48.2–63.5)230388,45359.2 (51.6–66.9)
Other forms of chronic ischemic heart disease (I20,I25)79340,05323.2 (18.4–29.0)88341,56625.8 (20.7–31.7)89351,33225.3 (20.3–31.2)111354,41931.3 (25.5–37.1)90370,65224.3 (19.5–29.8)113388,45329.1 (23.7–34.5)
Other heart diseases (I26–I51)53340,05315.6 (11.7–20.4)60341,56617.6 (13.4–22.6)46351,33213.1 (9.6–17.5)56354,41915.8 (11.9–20.5)68370,65218.3 (14.2–23.3)69388,45317.8 (13.8–22.5)
Table 9. ICD-10 113 Cause List for Cardiovascular Deaths for Native American Women Aged ≥35 years old in the State of Florida from the years 2020- 2023.
Table 9. ICD-10 113 Cause List for Cardiovascular Deaths for Native American Women Aged ≥35 years old in the State of Florida from the years 2020- 2023.
ICD-10 113 Cause ListNative American
2020202120222023
DeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude Rate
Diseases of heart (I00–I09,I11,I13,I20–I51)2154,77338.3 (23.7–58.6)2356,23240.9 (25.9–61.4)2458,10641.3 (26.5–61.5)2861,83745.3 (30.1–65.4)
Major cardiovascular diseases (I00–I78)2154,77338.3 (23.7–58.6)2356,23240.9 (25.9–61.4)2458,10641.3 (26.5–61.5)2861,83745.3 (30.1–65.4)
Table 10. ICD-10 113 Cause List for Cardiovascular Deaths for Native American Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
Table 10. ICD-10 113 Cause List for Cardiovascular Deaths for Native American Women Aged ≥35 years old in the State of Florida from the years 2018–2023.
ICD-10 113 Cause ListYear
Other Races
201820192020202120222023
DeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude RateDeathsPopulationCrude Rate
Diseases of heart (I00–I09,I11,I13,I20–I51)60235,99825.4 (19.4–32.7)58243,16023.9 (18.1–30.8)47252,17918.6 (13.7–24.8)49260,08118.8 (13.9–24.9)59272,73121.6 (16.5–27.9)60283,97521.1 (16.1–27.2)
All other forms of chronic ischemic heart disease (I20,I25.1–I25.9)22235,9989.3 (5.8–14.1)22243,1609.0 (5.7–13.7)23252,1799.1 (5.8–13.7)21260,0818.1 (5.0–12.3) 31283,97510.9 (7.4–15.5)
Ischemic heart diseases (I20–I25)36235,99815.3 (10.7–21.1)38243,16015.6 (11.1–21.5)37252,17914.7 (10.3–20.2)36260,08113.8 (9.7–19.2)39272,73114.3 (10.2–19.5)51283,97518.0 (13.4–23.6)
Major cardiovascular diseases (I00–I78)60235,99825.4 (19.4–32.7)58243,16023.9 (18.1–30.8)47252,17918.6 (13.7–24.8)49260,08118.8 (13.9–24.9)59272,73121.6 (16.5–27.9)60283,97521.1 (16.1–27.2)
Other forms of chronic ischemic heart disease (I20,I25)29235,99812.3 (8.2–17.6)30243,16012.3 (8.3–17.6)26252,17910.3 (6.7–15.1)28260,08110.8 (7.2–15.6)28272,73110.3 (6.8–14.8)40283,97514.1 (10.1–19.2)
Other heart diseases (I26–I51)24235,99810.2 (6.5–15.1)20243,1608.2 (5.0–12.7) 20272,7317.3 (4.5–11.3)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Puvvala, A.; Rohatgi, A.; Lobaina, D.; Srivastav, M.; Jhumkhawala, V.; Kaleem, S.; Sacca, L. Trends in Heart Disease Mortality Among US Female Adults Aged ≥35 Years Old in Florida: A Descriptive Analysis. Women 2025, 5, 37. https://doi.org/10.3390/women5040037

AMA Style

Puvvala A, Rohatgi A, Lobaina D, Srivastav M, Jhumkhawala V, Kaleem S, Sacca L. Trends in Heart Disease Mortality Among US Female Adults Aged ≥35 Years Old in Florida: A Descriptive Analysis. Women. 2025; 5(4):37. https://doi.org/10.3390/women5040037

Chicago/Turabian Style

Puvvala, Avanthi, Atharva Rohatgi, Diana Lobaina, Megha Srivastav, Vama Jhumkhawala, Sahar Kaleem, and Lea Sacca. 2025. "Trends in Heart Disease Mortality Among US Female Adults Aged ≥35 Years Old in Florida: A Descriptive Analysis" Women 5, no. 4: 37. https://doi.org/10.3390/women5040037

APA Style

Puvvala, A., Rohatgi, A., Lobaina, D., Srivastav, M., Jhumkhawala, V., Kaleem, S., & Sacca, L. (2025). Trends in Heart Disease Mortality Among US Female Adults Aged ≥35 Years Old in Florida: A Descriptive Analysis. Women, 5(4), 37. https://doi.org/10.3390/women5040037

Article Metrics

Back to TopTop